pcDNA3.1 SARS-CoV-2 N Citations (5)

Originally described in: Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant.
Yurkovetskiy L, Wang X, Pascal KE, Tomkins-Tinch C, Nyalile TP, Wang Y, Baum A, Diehl WE, Dauphin A, Carbone C, Veinotte K, Egri SB, Schaffner SF, Lemieux JE, Munro JB, Rafique A, Barve A, Sabeti PC, Kyratsous CA, Dudkina NV, Shen K, Luban J Cell. 2020 Sep 15. pii: S0092-8674(20)31229-0. doi: 10.1016/j.cell.2020.09.032. PubMed Journal

---

Articles Citing pcDNA3.1 SARS-CoV-2 N

Articles
Host Cellular RNA Helicases Regulate SARS-CoV-2 Infection. Ariumi Y. J Virol. 2022 Mar 23;96(6):e0000222. doi: 10.1128/jvi.00002-22. Epub 2022 Feb 2. PubMed
SARS-CoV-2 Spike Protein Mutation at Cysteine-488 Impairs Its Golgi Localization and Intracellular S1/S2 Processing. Yamamoto Y, Inoue T, Inoue M, Murae M, Fukasawa M, Kaneko MK, Kato Y, Noguchi K. Int J Mol Sci. 2022 Dec 13;23(24):15834. doi: 10.3390/ijms232415834. PubMed
The Antiviral Activity of the Lectin Griffithsin against SARS-CoV-2 Is Enhanced by the Presence of Structural Proteins. Bains A, Fischer K, Guan W, LiWang PJ. Viruses. 2023 Dec 18;15(12):2452. doi: 10.3390/v15122452. PubMed
Is there an immunological cross-reactivity of antibodies to the myelin oligodendrocyte glycoprotein and coronaviruses? Schanda K, Mariotto S, Rudzki D, Bauer A, Dinoto A, Rossi P, Ferrari S, Jarius S, Wildemann B, Boso F, Giometto B, Engels D, Kumpfel T, Wendel EM, Rostasy K, Reindl M. Brain Commun. 2024 Mar 25;6(2):fcae106. doi: 10.1093/braincomms/fcae106. eCollection 2024. PubMed
A viral assembly inhibitor blocks SARS-CoV-2 replication in airway epithelial cells. Du L, Deiter F, Bouzidi MS, Billaud JN, Simmons G, Dabral P, Selvarajah S, Lingappa AF, Michon M, Yu SF, Paulvannan K, Manicassamy B, Lingappa VR, Boushey H, Greenland JR, Pillai SK. Commun Biol. 2024 Apr 22;7(1):486. doi: 10.1038/s42003-024-06130-8. PubMed

If you have published an article using this material, please email us at to have your article added to this page.